Shares in Covid vaccine makers hit on worries waiver would harm profit and innovation
Home/FT/Pharma industry fears Biden’s patent move sets precedent FT Pharma industry fears Biden’s patent move sets precedent Financial Times0 Less than a minute Facebook X LinkedIn Shares in Covid vaccine makers hit on worries waiver would harm profit and innovation Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
